◼ Archived
Business
🔮 fades ✗
Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
Novo Nordisk has halted two clinical trials for Ziltivekimab, an experimental cardiovascular drug designed to reduce inflammation.